Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction.
about
N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart diseasePlasma N terminal pro-brain natriuretic peptide and cardiotrophin 1 are raised in unstable anginaCardiovascular disease, risk factors and heart rate variability in the elderly general population: design and objectives of the CARdiovascular disease, Living and Ageing in Halle (CARLA) StudyCardiopulmonary laboratory biomarkers in the evaluation of acute dyspneaPlasma brain natriuretic peptide concentrations in patients with valvular heart diseaseLeft atrial enlargement and NT-proBNP as predictors of sudden cardiac death in patients with heart failure.N-terminal proBNP and mortality in hospitalised patients with heart failure and preserved vs. reduced systolic function: data from the prospective Copenhagen Hospital Heart Failure Study (CHHF).Biomarkers in acute myocardial infarction.Effects of intracoronary injection of autologous bone marrow-derived stem cells on natriuretic peptides and inflammatory markers in patients with acute ST-elevation myocardial infarction.Diagnostic accuracy of plasma NT-proBNP levels for excluding cardiac abnormalities in the very elderly.Towards a blood test for heart failure: the potential use of circulating natriuretic peptides.Natriuretic peptides in the pathophysiology of congestive heart failure.Plasma tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9: novel indicators of left ventricular remodelling and prognosis after acute myocardial infarction.Novel neurohumoral factors in congestive heart failure: adrenomedullin.Value of N-terminal pro brain natriuretic peptide in predicting prognosis and severity of coronary artery disease in acute coronary syndrome.Relationship between obesity and N-terminal brain natriuretic Peptide level as a prognostic value after acute myocardial infarction.Heart failure and neuroendocrine activation: diagnostic, prognostic and therapeutic perspectives.Neprilysin Inhibition in Heart Failure with Reduced Ejection Fraction: A Clinical Review.The role of brain natriuretic peptide in the prediction of cardiac performance in coronary artery bypass grafting.Impact of percutaneous coronary intervention on biomarker levels in patients in the subacute phase following myocardial infarction: the Occluded Artery Trial (OAT) biomarker ancillary studyUsefulness of N-terminal pro-B-type natriuretic peptide in patients admitted to the intensive care unit: a multicenter prospective observational studyPlasma Brain Natriuretic Peptide (BNP) as an Indicator of Left Ventricular Function, Early Outcome and Mechanical Complications after Acute Myocardial Infarction.NT pro B type natriuretic peptide levels in constrictive pericarditis and restrictive cardiomyopathy.BNP was associated with ischemic myocardial scintigraphy and death in patients at chest pain unitSensitivity and specificity of NT-proBNP to detect heart failure at post mortem examinationPlasma adrenomedullin as an indicator of prognosis after acute myocardial infarction.Influence of hypertension, left ventricular hypertrophy, and left ventricular systolic dysfunction on plasma N terminal proBNP.Increased brain and atrial natriuretic peptides in patients with chronic right ventricular pressure overload: correlation between plasma neurohormones and right ventricular dysfunction.Left ventricular dysfunction, natriuretic peptides, and mortality in an urban populationCopeptin and risk stratification in patients with acute dyspnea.NT-proBNP: a new diagnostic screening tool to differentiate between patients with normal and reduced left ventricular systolic function.The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population.N-terminal pro B type natriuretic peptide, but not the new putative cardiac hormone relaxin, predicts prognosis in patients with chronic heart failure.Diagnostic and prognostic evaluation of left ventricular systolic heart failure by plasma N-terminal pro-brain natriuretic peptide concentrations in a large sample of the general populationN-Terminal Pro-B-type Natriuretic Peptide Is Useful to Predict Cardiac Complications Following Lung Resection Surgery.NT-proBNP in heart failure: therapy decisions and monitoring.Assessing the diagnostic test accuracy of natriuretic peptides and ECG in the diagnosis of left ventricular systolic dysfunction: a systematic review and meta-analysis.Adrenomedullin concentrations at two time points following myocardial infarction and prediction of mid-term outcomes.Admission N-terminal pro-brain natriuretic peptide and its interaction with admission troponin T and ST segment resolution for early risk stratification in ST elevation myocardial infarction.ProBNP-derived peptides in cardiac disease.
P2860
Q24607043-C9EB9882-DAC9-4E8C-A548-E6580C85F268Q24683609-0B295D25-6B6E-4501-8F70-E545C04BCE89Q24814820-544B03D4-98EB-4FB9-8277-F7A8AC233763Q26745756-0FA876FC-BBBF-4985-A4C7-122D75A84460Q28603050-3E1F9A59-8BA0-44C7-A57B-7B4690AE7D01Q30542622-DCAD4F65-659A-4539-8466-838CDDDE988DQ30908647-987B77E9-C2F9-4218-91C0-75E88030AA98Q33596823-49FE4E1C-B8B1-4944-9ED1-79BB3ED043DAQ33720841-B934CBC1-480A-457E-ABAE-2420E19B6402Q33744529-76417727-A96F-4483-BDD1-7F2FFBE5DA98Q33962030-4D8E22F0-C0D0-40D6-B28E-6A47ACDC651AQ34027488-C3FECA94-5ADC-4F52-886D-A7F4CD6A71ACQ34138706-4A6B22F5-84C7-4A17-AD07-40869C0A2DADQ34221042-5AD89A8E-96AF-4841-992A-07D1872B12BBQ34266208-B8C5A875-4FC0-49B0-9182-A7A2261427A9Q34434691-46C9FCAA-F051-4AA7-A1AF-417265A22774Q34448373-48928C2E-8A75-4046-B7A4-A33EE2C85FFAQ34495751-A10F9BE7-33D4-4CF8-B3DC-40E2FB0B0B94Q34796770-AC5F8145-ACCA-4C47-BD3A-F456E9A3EB0EQ35025805-8EABF7B3-BC45-487A-87C2-CA0DA22C474DQ35115701-98867709-0E4C-4664-AC3B-9259B69D8402Q35193187-93AE9D07-EACF-4F7E-9DF7-CF3B86C02D0EQ35244261-53324FC5-6E95-4BA2-AFF7-7EDBF62B642DQ35292436-E3561B74-262F-4DE9-8397-E4A74E12D127Q35332734-182D0E23-1D4C-4C76-80C7-9108A452A2BFQ35372009-3F169232-ED6A-4390-B479-5D162F2F6046Q35375245-D87E5B17-8ECA-4D46-86E6-671F17A4C30EQ35379951-0ACEB72D-86A8-4D0E-A469-A4D0725D9B05Q35380181-19256593-9B71-4F54-AA4A-E4749B0A3EC8Q35561316-541C4ECD-7A9B-4D5D-BB26-9D43A9CE3534Q35580797-671BA523-86B8-4A8D-9B75-04CA71E46E9DQ35581313-2DBE8D1C-8063-4B4C-99DA-30F244BB9DE1Q35581367-F077DEEC-1DB5-442B-9891-9E33AD313472Q35582125-1622F024-031D-44C4-A966-F8F8ED23B8D5Q35644493-10059879-FD27-47BA-9BD6-8E54648E3DDBQ35677310-EE94ED03-BB03-4AE7-A9C0-6CDBFCE001F8Q35678102-A9F1C30B-2031-4422-9240-72C5B4C8D4D3Q35691363-85E69AD5-AC11-465C-B191-60353063E523Q35770822-F7C9A1E8-9E15-46C6-84DD-352C3F9B561EQ35847164-D603BBC5-8603-47DF-86CF-F7264C0CDA4A
P2860
Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Plasma N-terminal pro-brain na ...... s after myocardial infarction.
@en
Plasma N-terminal pro-brain na ...... s after myocardial infarction.
@nl
type
label
Plasma N-terminal pro-brain na ...... s after myocardial infarction.
@en
Plasma N-terminal pro-brain na ...... s after myocardial infarction.
@nl
prefLabel
Plasma N-terminal pro-brain na ...... s after myocardial infarction.
@en
Plasma N-terminal pro-brain na ...... s after myocardial infarction.
@nl
P2093
P1433
P1476
Plasma N-terminal pro-brain na ...... s after myocardial infarction.
@en
P2093
Buttimore RC
Crozier IG
Elliott JM
Espiner EA
Frampton C
Lainchbury JG
Nicholls MG
Richards AM
P304
P356
10.1161/01.CIR.97.19.1921
P407
P577
1998-05-01T00:00:00Z